Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 703212
Submitted by lobbyist on: November 9, 2017 06:01:57 AM
Accepted by Registrar on: November 9, 2017 09:35:31 AM

Designated Filer Information

Keon, James J  
4120 Yonge Street Suite 409  
Toronto, ON, M2P 2B8
416-223-2333
Canada  

Organization Information

Canadian Generic Pharmaceutical Association (CGPA)  
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.
4120 Yonge Street Suite 409  
Toronto, ON, M2P 2B8
416-223-2333
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

November 9, 2017  
May 9, 2018  

Organization's In-House Lobbyists

 



Name: Connell, Jeff
 
November 9, 2017  
Inactivation Date: May 28, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Aligning BC's policies, legislation and regulations regarding listing and reimbursement of generic products with agreement being negotiated with the pan-Canadian Pharmaceutical Allicance. Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards.Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health November 9, 2017
Public Agency Health November 9, 2017

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Minister of State for Trade November 9, 2017

Name: Cox, Jody
 
November 9, 2017  
Inactivation Date: May 28, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Minister of State for Trade November 9, 2017

Name: Keon, James
 
November 9, 2017  
Inactivation Date: May 28, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Aligning BC's policies, legislation and regulations regarding listing and reimbursement of generic products with agreement being negotiated with the pan-Canadian Pharmaceutical Allicance. Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards.Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health November 9, 2017
Public Agency Health November 9, 2017

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Minister of State for Trade November 9, 2017